IL-12A p35 Antibody (C18.2): sc-517382

IL-12A p35 Antibody (C18.2) is a rat monoclonal IgG2a antibody that detects interleukin-12A p35 in mouse and rat samples through flow cytometry (FCM). IL-12A p35 is a crucial subunit of the heterodimeric cytokine interleukin-12, which plays a significant role in the immune response by promoting the differentiation of T helper cells and enhancing the production of interferon-γ (IFN-γ) from T cells and natural killer (NK) cells. Various antigen-presenting cells, including phagocytes and B cells, secrete this cytokine, which is vital for mediating antiviral immunity. IL-12A p35′s importance extends beyond its role as a signaling molecule to its ability to influence immune system responses to infections, such as those caused by Epstein-Barr virus (EBV) and cytomegalovirus (CMV). IL-12A p35 subunit functions as the biologically active component responsible for signal transduction through the IL-12 receptor, making anti-IL-12A p35 antibody (C18.2) an invaluable tool for researchers studying immune mechanisms and cytokine signaling pathways.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

IL-12A p35 Antibody (C18.2) References:

1. A study on the expression of interleukin (IL)-10 and IL-12 P35, P40 mRNA in the psoriatic lesions.  |  Cheng, J., et al. 2001. J Tongji Med Univ. 21: 86-8. PMID: 11523260
2. Production of biologically active equine interleukin 12 through expression of p35, p40 and single chain IL-12 in mammalian and baculovirus expression systems.  |  McMonagle, EL., et al. 2001. Equine Vet J. 33: 693-8. PMID: 11770992
3. Modulation of IL-12 p35 and p40 promoter activity by smokeless tobacco extract is associated with an effect upon activation of NF-kappaB but not IRF transcription factors.  |  Petro, TM. 2003. Int Immunopharmacol. 3: 735-45. PMID: 12757742
4. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1.  |  Liu, J., et al. 2003. J Exp Med. 198: 1265-76. PMID: 14568984
5. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells.  |  Goriely, S., et al. 2004. J Exp Med. 199: 1011-6. PMID: 15051764
6. IL-12 p35 silenced dendritic cells modulate immune responses by blocking IL-12 signaling through JAK-STAT pathway in T lymphocytes.  |  Xu, H., et al. 2007. Biochem Biophys Res Commun. 353: 812-6. PMID: 17194445
7. High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancer.  |  Wolf, AM., et al. 2010. Gynecol Oncol. 118: 244-50. PMID: 20603238
8. Contribution of interleukin-12 p35 (IL-12p35) and IL-12p40 to protective immunity and pathology in mice infected with Chlamydia muridarum.  |  Chen, L., et al. 2013. Infect Immun. 81: 2962-71. PMID: 23753624
9. Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.  |  Choi, IK., et al. 2013. PLoS One. 8: e67512. PMID: 23844018
10. Contribution of IL-12/IL-35 common subunit p35 to maintaining the testicular immune privilege.  |  Terayama, H., et al. 2014. PLoS One. 9: e96120. PMID: 24760014